Zacks Investment Research Analysts Reaffirm a "Neutral" Rating on Alexion …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those…
Mother Nature NetworkNew hope in fight against progeriaMother Nature NetworkCollins, now director of the NIH, had led one of the teams that discovered the genetic spelling mistake that causes the disease in 2003 and later became intrigued by a drug cal…
New Westminster band honours EvaNew Westminster News LeaderMarkvoort had a double lung transplant in 2007 but died two years ago from transplant rejection while awaiting a second transplant. Other members of the band are guitarist Len Osanic, who runs …
Alexion Pharmaceuticals Share Price Target Raised to $96.00 by Morgan Stanley …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in th…
Research Breakthrough Shows Promise in Offsetting Cornea Transplant RejectionHealthCanal.comMr Gerry Fahy, Consultant Ophthalmologist at University Hospital Galway, who was involved in this study, commented on the results of this study: “Prevention o…
19 year-old transplant patient sees new face for the first timemsnbc.comThe real impediment would have to be major transplant rejection… "95% chance you'll love your new hair… 4% chance you'll hate the lifelong rejection meds… 1% cha…
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and …Marketwire (press release)… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, includin…
2012 Economic Outlook — Report Highlights Alexion Pharmaceuticals, Inc. and …MarketWatch (press release)… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, includi…
Alexion Pharmaceuticals Shares Given New $68.00 Price Target by Jefferies …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the th…
Alexion Pharmaceuticals Shares Given New $89.00 Price Target by Analyst at …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the t…